Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Analytical Chemistry >  Standard >  Pharmaceutical Impurity Reference Standards >  3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-

Basic information Safety Supplier Related

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Basic information

Product Name:
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-
Synonyms:
  • 3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-
  • Avatrombopag Impurity 17 HCl
  • 5-chloro-N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-6-(dimethylamino)pyridine-3-carboxamide
  • Avatroposide impurities6
  • Avatrapa impurity 1
  • Mansonone G
  • 5-Chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide (Avatrombopag Impurity)
CAS:
2626934-45-8
MF:
C25H30Cl2N6OS2
MW:
565.58
Mol File:
2626934-45-8.mol
More
Less

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)- Chemical Properties

Density 
1.398±0.06 g/cm3(Predicted)
pka
4.49±0.70(Predicted)

3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-6-(dimethylamino)-Supplier

Beijing Comparison Pharmaceutical Technology Co., Ltd
Tel
010-52878169 15701683040
Email
sales@bjcomparison.com
Shijiazhuang yaoBo Pharmaceutical Co., Ltd.
Tel
15633056635
Email
2880679888@qq.com
Shenzhen Botel Biotechnology Co. Ltd.
Tel
0755-22202135 13316968096
Email
1979313431@qq.com
Guangzhou Dreampharm Biotechnology Co., Ltd.
Tel
020-36607679 17825480238
Email
3008233717@qq.com
Shanghai Xinlitai Pharmaceutical Co. , Ltd.
Tel
18616665298
Email
wenjie.li@bocimed.com